Johnson & Johnson named Tom Cavanaugh to lead Innovative Medicine as Jennifer Taubert retires after more than 21 years with J ...

Two newly published papers underscore the need for increased awareness, caregiver education, and preparedness to help ensure timely use of epinephrine during severe allergic reactions ...

There's a change at the helm of Johnson & Johnson's pharma division in the offing, as executive vice president Jennifer ...

Keytruda made Merck an oncology powerhouse, but as the patent cliff looms, its business development leader outlines what’s ...

LOTTE Holdings Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in Metaphore Biotechnologies, Inc. (Headquarters: Cambridge, MA, USA; CEO: Angela ...

A massive analysis of immune cells in human tissue is yielding clues to the root causes of lung and autoimmune diseases.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial-stage ...

BROADEN2 Phase 2b AD trial nearly six months ahead of anticipated timeline, with data expected by year-end 2026 ...

Lymphocytes are central orchestrators of immune responses, integrating signals from activating and inhibitory receptors, cytokines, and metabolic pathways ...

Macrophages formed in the bone marrow can only assume the function of embryonal phagocytes, or "scavenger cells," to a certain degree according to a study by the University of Bonn and the Peter ...

As we age, chronic inflammation-or "inflammaging"-increases throughout the body and weakens our ability to fight cancer.

A new study co-led by professor Valeriya Malysheva, group leader at the VIB-UAntwerp Center for Molecular Neurology, ...